Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assessments | Screen | Random | Surgery* | First until third PO | W 1 | W 4 | M 3 | M 6 | M 9 | M 12 | M 15 | M 18 | M 21 | M 24 | M 28 | M 32 | M 36 | M 40 | M 44 | M 48 | M 52 | M 56 | M 60 |
Informed consent | X | ||||||||||||||||||||||
Medical history | X | ||||||||||||||||||||||
Physical examination | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||
Medical assessment | X | X | X | X | X* | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
Concomitant medication | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
Inclusion/exclusion criteria | X | X | |||||||||||||||||||||
Randomisation | X | ||||||||||||||||||||||
Adverse events | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
Nerve conduction studies | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||
Nutritional assessment | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
SF-36, IPSS and OAB-Qsf | X | X | X | X | X | X | |||||||||||||||||
Urinary diary | X | X | X | X | X | X | X | X | |||||||||||||||
Serum pregnancy test | X | ||||||||||||||||||||||
CBC | X | X | X | X | X | X | X | ||||||||||||||||
AST/ALT | X | X | X | X | X | X | |||||||||||||||||
Amylase | X | X† | X† | X | X | X | |||||||||||||||||
Sodium and potassium | X | ||||||||||||||||||||||
Urea and creatinine | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||
PT and aPPT | X | ||||||||||||||||||||||
Lipids | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||
Fasting plasma glucose | X | X* | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
HbA1c | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||
Microalbumin and creatinine | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||
Iron and ferritin | X | X | X | X | X | X | X | ||||||||||||||||
Calcium, PTH and vitamin D | X | X | X | X | X | X | X | X | |||||||||||||||
Folic acid | X | X | X | X | X | X | |||||||||||||||||
Vitamin A, B1 and B12 | X | X | X | X | X | X | X | ||||||||||||||||
Anti-GAD | X | ||||||||||||||||||||||
PSA | X | ||||||||||||||||||||||
PCR | X | X* | X* | X* | X* | X* | X* | X* | X* | X* | X* | X* | |||||||||||
HIV test | X | ||||||||||||||||||||||
MMTT | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||
Urine sample (DNA) | X | X | X | X | X | X | X | ||||||||||||||||
Urinalysis | X | X | X | X* | X | X | |||||||||||||||||
Chest X-ray | X | ||||||||||||||||||||||
Abdominal ultrasound | X | ||||||||||||||||||||||
ECG | X | ||||||||||||||||||||||
Echocardiogram | X | X | |||||||||||||||||||||
Upper digestive endoscopy | X | ||||||||||||||||||||||
Elastrography ultrasound | X | X | X | X | X | X | |||||||||||||||||
Detailed eye examination | X | X | X | X | X | ||||||||||||||||||
Vital signs | X | X | X | X | X* | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
Weight | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
Height | X | ||||||||||||||||||||||
Dispensing drugs | X | X | X | X* | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
RYGB | X | ||||||||||||||||||||||
Glucose monitoring | X* | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
*Procedure exclusive for surgical arm.
†Procedure exclusive for clinical arm.
ALT, serum glutamic-pyruvic transaminase; aPPT, activated partial thromboplastin time; CBC, complete blood count; GAD, glutamic acid decarboxylase; HbA1c, glycated haemoglobin; IPSS, nternational Prostate Symptom Score; MMTT, Mixed Meal Tolerance Test; OAB-Qsf, Overactive Bladder Questionnaire Short Form; PO, orally; PT, prothrombin time; PSA, prostate-specific antigen; PTH, parathyroid hormone; RYGB, Roux-en-Y gastric bypass; SF-36, 36-item Short Form Health Survey.